Next Article in Journal
Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria
Previous Article in Journal
Flavonoids from Nelumbo nucifera Gaertn., a Medicinal Plant: Uses in Traditional Medicine, Phytochemistry and Pharmacological Activities
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessArticle

Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults

1
Center for Nutrition and Health Research (CINyS), National Institute of Public Health (INSP), Cuernavaca, Morelos 62100, México
2
Coordination for the Innovation and Application of Science and Technology (CIACYT), Autonomous University of San Luis Potosí (UASLP), San Luis Potosí, San Luis Potosí 78210, Mexico
3
Department of Nutrition, University of Central Mexico (UCEM), San Luis Potosí, San Luis Potosí 78250, Mexico
4
Department of Pharmacy, University of Guanajuato (UG), Guanajuato, Guanajuato 36050, Mexico
5
Department of Medical Science, University of Guanajuato, León, Guanajuato 37320, Mexico
*
Author to whom correspondence should be addressed.
Medicines 2018, 5(4), 128; https://doi.org/10.3390/medicines5040128
Received: 31 October 2018 / Revised: 22 November 2018 / Accepted: 27 November 2018 / Published: 1 December 2018
(This article belongs to the Special Issue Application of Glycobiology in the Treatment of Diseases)
  |  
PDF [309 KB, uploaded 1 December 2018]

Abstract

Background: Consumption of dietary advanced glycation end products is linked to metabolic syndrome. The objective was to describe the association between dietary advanced glycation end products intake and metabolic syndrome in young Mexican adults. Methods: The present was a cross-sectional study in 126 Mexican adults 18–35 years old evaluating metabolic syndrome through the harmonized criteria. Macronutrients and dietary advanced glycation end products intake were estimated through three 24-hour dietary recalls and food composition tables. Association between metabolic syndrome and high advanced glycation end products intake (≥10,000 kU/day) was evaluated through three logistic regression models adjusted by sex, age, family history of cardiometabolic diseases and energy intake. Results: Subjects with a higher advanced glycation end products intake were more likely to have impaired fasting glucose (OR: 4.91, 95% CI 1.29–18.60, p < 0.05) and metabolic syndrome (OR: 2.67, 95% CI 0.96–7.44, p = 0.059) than those participants with low consumption of these products after adjustment of sex, age, family history of cardiovascular disease and energy intake. Conclusions: High intake of dietary advanced glycation end products was significantly associated with impaired fasting glucose and marginally with metabolic syndrome in young Mexican adults regardless of sex, age, family history of cardiovascular disease and energy intake. View Full-Text
Keywords: advanced glycation end products; diet; metabolic syndrome; young adults advanced glycation end products; diet; metabolic syndrome; young adults
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Mendoza-Herrera, K.; Aradillas-García, C.; Mejía-Diaz, M.A.; Alegría-Torres, J.A.; Garay-Sevilla, M.E.; Luevano-Contreras, C. Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults. Medicines 2018, 5, 128.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicines EISSN 2305-6320 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top